Sean Tucker - 28 Mar 2022 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role: SVP, Chief Scientific Officer
Signature: /s/ Sean Tucker
Issuer symbol: VXRT
Transactions as of: 28 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 30 Mar 2022, 21:19:42 UTC
Previous filing: 11 Aug 2021
Next filing: 25 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VXRT	Common Stock	Award	$0	+43,750	+100%	$0.000000	87,631	28 Mar 2022	Direct	F1
holding	VXRT	Common Stock						51,465	28 Mar 2022	By joint tenancy with Frances Chang and Sean Tucker
holding	VXRT	Common Stock						9,060	28 Mar 2022	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VXRT	Stock Option (right to buy)	Award	$0	+262,500		$0.000000	262,500	28 Mar 2022	Common Stock	262,500	$5.09	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the fourth anniversary of the grant date.
F2	The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 28, 2023, the first anniversary of the date that the grant was approved by the board of directors, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 28, 2026.